FDA Approves Larger Vial Size for Nelarabine Injection in T-ALL and T-LBL

The FDA approved a larger 375mg/75mL vial size of nelarabine for T-ALL and T-LBL, enhancing dosing flexibility and addressing shortages.

Read OncLive Article